Illumina (ILMN) Said to Have Purchase Moleculo, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts ILMN Hot Sheet
Join SI Premium – FREE
Illumina, Inc. (NASDAQ: ILMN) said it purchase Moleculo, Inc. The news comes as it filed an 8-K earlier disclosing that it withdrew its offer for Complete Genomics (Nasdaq: GNOM).
The biotech is presenting at the JPMorgan Global Healthcare Conference today. Shares are up 1.8 percent on the session.
The biotech is presenting at the JPMorgan Global Healthcare Conference today. Shares are up 1.8 percent on the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Starbucks Has Explored Takeover Of Chipotle - FT
- Tevogen Bio signs non-binding letter of intent with HRK Healthcare
- Illumina (ILMN) PT Raised to $200 at Barclays
Create E-mail Alert Related Categories
Insiders' Blog, Mergers and AcquisitionsRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
